Keyphrases
Ischemia
100%
Developmental Endothelial locus-1
50%
Dynamic Continous
50%
Angiogenic Proteins
50%
Cyclooxygenase-2 Inhibitors
50%
Cardiovascular Risk
50%
COX-2 Inhibitors
50%
Continuous murmur
50%
Exertional
50%
Coil Embolization
50%
Hypercholesterolemia
50%
Subclavian Steal
50%
Hypertension
50%
Ventricular Arrhythmia
50%
Right Coronary Artery
50%
Atrial Fibrillation
50%
Coronary Angiography
50%
Coronary Artery Fistula
50%
Left Ventricular Function
50%
II-VI
50%
Dyspnea
50%
Older Men
50%
Coronary Sinus
50%
Fistula
50%
Stress Echocardiography
50%
Presyncope
50%
Cyclooxygenase-2
37%
Meta-analysis
25%
Class Effect
25%
Rofecoxib
25%
Endothelial Function
25%
Thromboxane A2 (TXA2)
25%
Prostacyclin
25%
Celecoxib
25%
Angiogenesis
23%
Relative Selectivity
12%
Platelets
12%
Homeostasis
12%
Prothrombotic State
12%
Published Data
12%
Cyclooxygenase-1 (COX-1)
12%
LDL Cholesterol
12%
Meloxicam
12%
Endothelium-dependent Vasodilation
12%
Aspirin
12%
Platelet Inhibition
12%
Platelet Aggregation
12%
Trial Publication
12%
Vasodilation
12%
C-reactive Protein
12%
Medicine and Dentistry
Ischemia
75%
Angiogenic Protein
50%
Angiogenesis
50%
Fistula
50%
Coronary Artery Fistula
50%
Hindlimb
31%
Coronary Steal
25%
Atrial Fibrillation
25%
Endovascular Coiling
25%
Hypercholesterolemia
25%
Coronary Angiography
25%
Dyspnea
25%
Right Coronary Artery
25%
Coronary Sinus
25%
Stress Echocardiography
25%
Heart Ventricle Arrhythmia
25%
Precordium
25%
Exercise
25%
Presyncope
25%
Capillary
12%
Fibroblast Growth Factor 2
12%
Discoidin
12%
Intramuscular Injection
12%
Perfusion Weighted Imaging
6%
Gadolinium
6%
Immunohistochemistry
6%
Blood Flow
6%
Extracellular Matrix Protein
6%
Endothelial Cell
6%
Protein Expression
6%
Femoral Artery
6%
Therapeutic Agent
6%
Densitometry
6%
Morphometrics
6%
Pharmacology, Toxicology and Pharmaceutical Science
Angiogenic Protein
50%
Ischemia
50%
Cardiovascular Risk
50%
COX-2 Inhibitor
50%
Fibroblast Growth Factor 2
33%
Discoidin
33%
Celecoxib
30%
Rofecoxib
30%
Observational Study
20%
Thromboxane A2
20%
Prostacyclin
20%
Acetylsalicylic Acid
20%
Gadolinium
16%
Intramuscular Injection
16%
Matrix Protein
16%
Case-Control Study
10%
Meloxicam
10%
Inflammation
10%
Low Density Lipoprotein Cholesterol
10%
APC
10%
C Reactive Protein
10%
Heparin
10%
Acute Coronary Syndrome
10%
Randomized Controlled Trial
10%
Clinical Trial
10%
Cyclooxygenase 1
10%
